Skip to main content
Premium Trial:

Request an Annual Quote

New Products: Oxford Gene Technology's CytoSure ISCA+SNP Array; Scienion's SciReader CL


Oxford Gene Technology this week launched its CytoSure ISCA +SNP Array. Agilent Technologies manufactures the chip. Four, 180,000-marker arrays are printed on each slide.

OGT said its new array combines array comparative genomic hybridization probes, endorsed by the International Standards for Cytogenomic Arrays Consortium, with validated SNP content that allows users to detect copy number changes and loss of heterozygosity. The array includes content designed to focus on disease and syndrome-associated regions, in addition to offering whole-genome coverage.

OGT provides all users of its CytoSure arrays with its CytoSure Interpret Software.

Scienion this week introduced its SciReader CL array imaging platform. SciReader CL enables the colorimetric detection of multiplex assays and is suitable for all kinds of multiplex assays in planar array formats such as microtiter plates and slides, according to the Berlin-based firm. Image acquisition and analysis software are also optimized for 96-well formats.

SciReader comes with software and multiple features, including automated spot finding and evaluation of single arrays or array batches. It also allows for customization of array analysis and report formats. Ready to use applications include DNA and protein multi-parameter analysis, genotyping and pathogen identification, the firm said.

The Scan

Support for Moderna Booster

An FDA advisory committee supports authorizing a booster for Moderna's SARS-CoV-2 vaccine, CNN reports.

Testing at UK Lab Suspended

SARS-CoV-2 testing at a UK lab has been suspended following a number of false negative results.

J&J CSO to Step Down

The Wall Street Journal reports that Paul Stoffels will be stepping down as chief scientific officer at Johnson & Johnson by the end of the year.

Science Papers Present Proteo-Genomic Map of Human Health, Brain Tumor Target, Tool to Infer CNVs

In Science this week: gene-protein-disease map, epigenomic and transcriptomic approach highlights potential therapeutic target for gliomas, and more